CVR number 28305222
Industry 75.0000 Veterinary activities

Dyreklinikken Fugl Thomsen ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  4.0% 4.4% 8.3% 6.2% 2.8%  
Credit score (0-100)  51 47 28 37 58  
Credit rating  BBB BBB BB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  5,165 6,592 7,623 8,740 10,527  
EBITDA  397 595 -17.2 95.6 2,585  
EBIT  356 553 -58.5 20.7 2,401  
Pre-tax profit (PTP)  399.8 618.1 19.1 137.3 2,456.4  
Net earnings  310.1 486.2 25.0 119.1 1,907.1  
Pre-tax profit without non-rec. items  400 618 19.1 137 2,456  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  143 101 59.9 198 801  
Shareholders equity total  2,332 2,707 2,532 2,537 4,326  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 278  
Balance sheet total (assets)  4,443 5,274 4,439 4,587 7,389  
Net Debt  -775 -1,698 -1,076 -1,089 -2,837  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,165 6,592 7,623 8,740 10,527  
Gross profit growth  16.4% 27.6% 15.6% 14.7% 20.4%  
Employees  12 16 18 20 17  
Employee growth %  9.1% 33.3% 12.5% 11.1% -15.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,443 5,274 4,439 4,587 7,389  
Balance sheet change%  14.7% 18.7% -15.8% 3.3% 61.1%  
Added value  397.2 594.7 -17.2 62.0 2,585.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -83 -83 -83 64 418  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 -1.0 1.0 2.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  6.9% 8.4% -0.8% 0.2% 22.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  9.7% 12.9% 0.9% 3.2% 41.3%  
ROI %  16.6% 23.1% 1.6% 5.8% 69.0%  
ROE %  13.9% 19.3% 1.0% 4.7% 55.6%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  52.5% 51.3% 57.0% 55.4% 58.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -195.1% -285.6% 6,262.8% -1,139.9% -109.7%  
Gearing %  0.0% 0.0% 0.0% 0.0% 6.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 11.4%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.1 1.7 1.8 0.7 1.1  
Current Ratio  2.4 1.9 2.2 1.0 1.4  
Cash and cash equivalent  774.8 1,698.4 1,076.0 1,089.3 3,114.4  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  2,439.7 2,434.0 2,252.1 63.0 1,131.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  33 37 -1 3 152  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  33 37 -1 5 152  
EBIT / employee  30 35 -3 1 141  
Net earnings / employee  26 30 1 6 112